Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paraphilic fantasies and disorders in Brazil: insights from a nationwide study on prevalence, risk factors, and public health implications.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2025
Same author

The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: The compass between neuro and somatoprogression.

Progress in neuro-psychopharmacology & biological psychiatry·2025
Same author

Correction: Depression, Self-Esteem, and Resilience and its Relationship with Psychological Features of Sexuality among Transgender Men and Women from Brazil.

Archives of sexual behavior·2025
Same author

The relevance of endoplasmic reticulum lumen and Anoctamin-8 for major depression: Results from a systems biology study.

Journal of psychiatric research·2025
Same author

Application of the transgender male voice questionnaire in a Brazilian population sample.

Frontiers in public health·2024
Same author

Coping strategies employed by transgender youth with higher and lower quality of life.

The British journal of developmental psychology·2024
Same journal

Haloperidol and QTc Prolongation in Adults With Psychiatric or Behavioral Indications: A Systematic Review and Meta-analysis.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same journal

Brazilian Psychiatric Association: 60th anniversary.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same journal

Brazil's zolpidem crisis: structural lessons from the first wave of the US opioid epidemic.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same journal

Risk factors associated with mental health outcomes and related conditions in graduate students: a systematic review.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same journal

Advances in Prescription Drug Control: Proposals to Strengthen the Regulation of Psychostimulants, Z-Drugs, and Benzodiazepines in Brazil.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same journal

Risky Alcohol Use Among University Students: Associated Factors and Changes Over a Decade.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

[Electroconvulsive therapy in major depression: current aspects].

Paula Barros Antunes1, Moacyr Alexandro Rosa, Paulo Silva Belmonte-de-Abreu

  • 1Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, and Programa de Esquizofrenia, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. antunespaula@hotmail.com

Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|July 1, 2009
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) is a highly effective treatment for depression, surpassing antidepressant medications. ECT offers significant symptom remission rates and improves patients' quality of life.

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Jun 22, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Medicine

Context:

  • Depression is a prevalent and debilitating mental health condition.
  • Electroconvulsive therapy (ECT) has a long-standing history in psychiatric treatment.
  • The efficacy and safety of ECT continue to be areas of active research and refinement.

Purpose:

  • To review the established efficacy of electroconvulsive therapy (ECT) in treating depressive symptoms.
  • To highlight current aspects of ECT practice, including patient perception and quality of life.
  • To underscore the role of ECT as a leading biological treatment for depression.

Summary:

  • Electroconvulsive therapy (ECT) demonstrates superior efficacy compared to antidepressant medications for depression.
  • ECT achieves depression remission rates generally ranging from 50% to 80%.
  • While effects on brain-derived neurotrophic factor are debated, ECT positively impacts quality of life and patient perception.

Impact:

  • ECT remains a crucial and highly effective intervention for treatment-resistant depression.
  • Advancements in ECT techniques enhance its safety and utility for acute and preventative care.
  • This review reinforces ECT's position as a vital therapeutic option in managing severe depressive disorders.